These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9795473)
1. Antimicrobial resistance in Helicobacter pylori: a global overview. Glupczynski Y Acta Gastroenterol Belg; 1998; 61(3):357-66. PubMed ID: 9795473 [TBL] [Abstract][Full Text] [Related]
2. Resistance of Helicobacter pylori to antibiotics. Mégraud F Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():43-53. PubMed ID: 9146790 [TBL] [Abstract][Full Text] [Related]
3. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534 [TBL] [Abstract][Full Text] [Related]
4. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514 [TBL] [Abstract][Full Text] [Related]
5. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715 [TBL] [Abstract][Full Text] [Related]
6. Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. The current situation. Mégraud F; Occhialini A; Doermann HP J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():25-38. PubMed ID: 9440053 [TBL] [Abstract][Full Text] [Related]
7. [Resistance to antibiotics used in Helicobacter pylori infection in children]. Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668 [TBL] [Abstract][Full Text] [Related]
9. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862 [TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617 [TBL] [Abstract][Full Text] [Related]
11. Recent trends in primary antimicrobial resistance of Helicobacter pylori in Finland. Kostamo P; Veijola L; Oksanen A; Sarna S; Rautelin H Int J Antimicrob Agents; 2011 Jan; 37(1):22-5. PubMed ID: 21084175 [TBL] [Abstract][Full Text] [Related]
12. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Lee JW; Kim N; Kim JM; Nam RH; Chang H; Kim JY; Shin CM; Park YS; Lee DH; Jung HC Helicobacter; 2013 Jun; 18(3):206-14. PubMed ID: 23241101 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140 [TBL] [Abstract][Full Text] [Related]
15. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS J Gastroenterol; 1998; 33 Suppl 10():62-5. PubMed ID: 9840021 [TBL] [Abstract][Full Text] [Related]
16. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Boyanova L; Mitov I Expert Rev Anti Infect Ther; 2010 Jan; 8(1):59-70. PubMed ID: 20014902 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study. Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405 [TBL] [Abstract][Full Text] [Related]
18. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? McNulty CA; Lasseter G; Shaw I; Nichols T; D'Arcy S; Lawson AJ; Glocker E Aliment Pharmacol Ther; 2012 May; 35(10):1221-30. PubMed ID: 22469191 [TBL] [Abstract][Full Text] [Related]
19. Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media. Yuen B; Zbinden R; Fried M; Bauerfeind P; Bernardi M Infection; 2005 Apr; 33(2):77-81. PubMed ID: 15827875 [TBL] [Abstract][Full Text] [Related]
20. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]